| Previous close | 66.16 |
| Open | 66.15 |
| Bid | 65.18 x 700 |
| Ask | 66.48 x 100 |
| Day's range | 65.83 - 66.40 |
| 52-week range | 55.11 - 66.80 |
| Volume | 7,576,421 |
| Avg. volume | 8,994,340 |
| Market cap | 180.3B |
| Beta | 0.97 |
| PE ratio (TTM) | 42.01 |
| EPS (TTM) | 1.57 |
| Earnings date | 28 Jul 2017 |
| Dividend & yield | 1.88 (2.84%) |
| Ex-dividend date | 2017-06-13 |
| 1y target est | 69.35 |
- Motley Fool•20 hours ago
The 3 Top Stocks for Your IRA in June
These companies appear poised for long-term outperformance.
- Motley Fool•21 hours ago
Better Buy: Merck & Co. Inc. vs. AbbVie Inc.
Which drug stock can make investors more money over the long run -- Merck or AbbVie?
- Motley Fool•2 days ago
The FDA Has Never Approved a Drug Like This in Its 111-Year History
This cancer drug produced data so incredible that the FDA approved it immediately for a specific genetic mutation, regardless of cancer location.
